What vitamin A dose, frequency, and duration should be administered to pediatric patients (infants <6 months, 6‑12 months, and 12 months‑<5 years) for treatment of deficiency and for prophylaxis?

Vitamin A Dosing in Pediatric Patients by Age

For prophylaxis in high-risk populations, children 12 months to 5 years should receive 200,000 IU every 3 months, infants under 12 months should receive 100,000 IU every 3 months (total 400,000 IU in first year), and for treatment of clinical deficiency (xerophthalmia), give 200,000 IU on day 1,200,000 IU on day 2, and 200,000 IU at 1-4 weeks (half doses for infants <12 months). 1, 2

Prophylactic Supplementation by Age Group

Infants <6 Months

• Dose: 100,000 IU every 3 months 1
• Frequency: Every 3 months if reliable dosing schedule can be maintained 1
• Alternative regimen: 200,000 IU every 6 months if 3-month dosing is impractical 1
• Single-dose option: 200,000 IU once if subsequent dosing is unlikely 1
• Total first-year dose: 400,000 IU administered across the year 1, 2
• Maternal supplementation: Mothers should receive 200,000 IU within 2 months postpartum to provide adequate vitamin A in breast milk 1, 2, 3

Infants 6-12 Months

• Dose: 100,000 IU every 3 months 1, 2
• Frequency: Every 3 months in high-risk populations or areas with endemic deficiency 1
• Duration: Continue through first year of life 1

Children 12 Months to <5 Years

• Dose: 200,000 IU every 3 months 1, 2
• Frequency: Every 3-6 months in populations at risk for vitamin A deficiency 1, 2
• Duration: Continue until 5 years of age 1

Treatment of Clinical Vitamin A Deficiency (Xerophthalmia)

Full Treatment Schedule for All Ages

This is a medical emergency requiring immediate high-dose vitamin A. 1, 4, 5

• Day 1: 200,000 IU orally 1, 2, 4
• Day 2: 200,000 IU orally 1, 2, 4
• Week 1-4: 200,000 IU orally (single dose) 1, 2, 4

Infants <12 Months with Clinical Deficiency

• Use half doses: 100,000 IU on day 1, day 2, and at 1-4 weeks 1, 2

Clinical Indications for Treatment Doses

• Xerophthalmia (night blindness, conjunctival xerosis, Bitot's spots) 1, 4
• Corneal xerosis, corneal ulceration, or keratomalacia 1, 4
• Severe malnutrition (weight-for-height Z-score <-3) 1
• Measles (two doses of 200,000 IU on consecutive days) 6

Special Populations and Contexts

Premature Infants on Parenteral Nutrition

• Dose: 700-1500 IU/kg/day (227-455 µg/kg/day) 1, 7
• Administration: Must be given with lipid emulsion, not water-based solutions 1, 7
• Rationale: Reduces bronchopulmonary dysplasia and oxygen requirements 7
• Monitoring: Serum retinol <200 µg/L (0.7 µmol/L) indicates deficiency 7

Term Infants on Parenteral Nutrition

• Dose: 150-300 µg/kg/day (approximately 2300 IU/day) 1, 7
• Administration: With lipid emulsion to prevent >60% loss 7

Older Children on Parenteral Nutrition

• Dose: 150 µg/day 1, 7

Risk Factors Requiring Prophylactic Supplementation

Provide vitamin A supplements when any of these conditions exist: 1

• Population originates from geographic area at high risk for vitamin A deficiency 1
• Evidence of severe vitamin A deficiency in the population 1
• General ration provides <2,000-2,500 IU/person/day 1

Monitoring and Documentation

Laboratory Assessment

• Normal range (>6 months): Serum retinol 1.05-2.8 µmol/L (300-800 µg/L) 7
• Deficiency: <0.70 µmol/L (200 µg/L) 8
• Adequate status: >1.05 µmol/L (300 µg/L) 8
• Severe deficiency (premature infants): <100 µg/L (0.35 µmol/L) indicates depleted liver stores 7

Documentation Requirements

• Document all vitamin A doses on the child's growth record chart 1, 2
• Recheck vitamin A levels 3 months after treatment 2

Critical Pitfalls to Avoid

Administration Errors

• Never use water-based solutions for parenteral vitamin A: More than 60% is lost; always use lipid emulsion 1, 7
• Do not underdose infants <12 months with clinical deficiency: They require half the standard treatment dose (100,000 IU), not lower 1, 2

Dosing Confusion

• Prophylaxis vs. treatment doses are vastly different: Prophylactic doses are 100,000-200,000 IU every 3 months; treatment requires 200,000 IU on consecutive days 1, 2
• Age-specific dosing is critical: Infants <12 months receive half doses for treatment but age-appropriate doses for prophylaxis 1

Toxicity Risk

• Narrow therapeutic window: The difference between deficiency and toxicity is small 1, 2
• Acute toxicity symptoms: Increased intracranial pressure, headache, nausea, vomiting, vertigo, blurred vision 2
• Chronic toxicity symptoms: Bone abnormalities, dermatitis, alopecia, ataxia, muscle pain 2
• Pregnancy considerations: Retinol is teratogenic; keep intake <10,000 IU/day in women of childbearing potential 1, 3

Clinical Context

• Treat corneal xerophthalmia as a medical emergency: Immediate high-dose vitamin A prevents blindness 1, 4, 5
• Measles requires treatment doses: Two consecutive daily doses of 200,000 IU reduce mortality by 64% and pneumonia-specific mortality by 67% 6